Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417).
2025 · 2nd Quarter (Apr 1 - June 30)
ACCENDRA HEALTH INC.
Filed by ACCENDRA HEALTH INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 16, 2025
- Income
- Not reported
- Expenses
- $200,000.00
- Registrant
- ACCENDRA HEALTH INC.
- Client
- ACCENDRA HEALTH INC.
- Filing UUID
- 27448d87-4865-4916-ab24-949d04ce9451
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Literal federal measure citations: H.R. 2005, H.R. 2902, S. 1406
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.